Invezz·2025-11-27 19:15Core Viewpoint - US stocks have experienced a significant uptrend, with the S&P 500 index rising over 35% since its low in April, yet certain outperforming stocks remain undervalued heading into 2026, presenting potential investment opportunities [4][6]. Group 1: CVS Health - CVS Health has seen a remarkable increase in its stock price, climbing over 78% this year, while trading at a forward earnings multiple of just 11x, which is below the S&P 500 average [7][5]. - The company reported strong Q3 financials and raised its earnings guidance, attributing this to the strength in its insurance business [7]. - Technical indicators show CVS stock is above all major moving averages, and the consensus rating is a "strong buy," with a target price suggesting nearly 20% upside potential [8]. - CVS also offers a healthy dividend yield of 3.33%, making it an attractive option for investors [9]. Group 2: Micron Technology - Micron Technology's stock has nearly tripled since the beginning of the year, yet it maintains a modest forward earnings multiple of 12x [10]. - The company is benefiting from a shortage in dynamic random-access memory (DRAM), which is driving earnings growth, and it has a consensus "buy" rating with price targets suggesting nearly 50% upside potential [11][10]. - The demand for chips related to artificial intelligence (AI) further enhances Micron's growth prospects, making it a standout candidate for investment in 2026 [11]. Group 3: Newmont Corporation - Newmont Corporation, the largest gold producer globally, has outperformed the broader market, with its stock valuation at 5x sales, which is attractive compared to peers [12]. - The stock serves as a hedge against market volatility and policy uncertainty, especially with stable gold prices anticipated heading into 2026 [12]. - Newmont offers a dividend yield of 1.1%, appealing to income-focused investors while providing defensive qualities and growth potential outside of tech and healthcare sectors [13].